Intrahepatic cholangiocarcinoma patient with epidermal growth factor receptor exon 19 deletion unresponsive to Afatinib monotherapy: a case report
Abstract Background The efficacy of epidermal growth factor receptor EGFR tyrosine kinase inhibitors in cholangiocarcinoma (CCA) patients is still unknown. Here, we report a 67-year-old CCA patient with EGFR exon 19 deletion receiving afatinib treatment. Case description A 67-year-old male was refer...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer
2025-04-01
|
| Seri Bilgileri: | Discover Oncology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1007/s12672-025-02271-2 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|